Loading the section
The price of Liquidia Corporation (LQDA) on October 9, 2026 is 27.38 USD, -2.28% on the day. Over 52 weeks the stock traded between 21.94 USD and 93.61 USD; the price now sits 8% of the way up that range. Over the past year the price changed by +13.70%. The P/E ratio is 111.5, which is above the sector median (24.8). Market capitalization is 2.49 billion USD, rank 61 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 02 November 2026 · Earnings calendar
Liquidia Corporation trades on Nasdaq under the ticker LQDA. The company belongs to the Health care sector. The trading history on this page starts on 26 July 2018.
Over the past 52 weeks LQDA has traded between 21.94 $ and 93.61 $. As of 09 October 2026 the price stood 7.59 % of the way from the 52-week low to the high.
Over one year LQDA shares rose 13.70 %; over six months they fell 28.98 %. Volatility over 90 days is 155.87 %. Dividends are not included: this is price change only, as of 09 October 2026.
LQDA trades at a price-to-earnings ratio of 111, above the sector median of 24.8. Price to sales is 8.6, above the sector median of 3.9. Price to book is 22.9, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 27.06 | 28.53 | 26.67 | 27.38 | 4M |
| 08 October 2026 | 26.34 | 29.35 | 26.34 | 28.02 | 5M |
| 07 October 2026 | 25.55 | 27.33 | 24.59 | 26.68 | 7M |
| 06 October 2026 | 27.95 | 28.30 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Liquidia Corporation (LQDA) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 158.3m $, net income was -68.9m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560, US
Liquidia Corporation reported revenue of 288M $ and net income of 22M $ over the last four quarters. Net margin is 7.74 %. Revenue changed by +1,936.66 % year over year. Earnings per share are 0.17 $. Market capitalisation is 2.5B $.
LQDA has a return on equity of 20.54 %, above the sector median of −41.68 %. Return on assets is 5.55 %, above the sector median of −32.11 %. Operating margin is 15.81 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 25.76 |
| 25.91 |
| 5M |
| 05 October 2026 | 28.07 | 28.48 | 25.92 | 27.64 | 8M |
| 02 October 2026 | 26.69 | 29.18 | 26.31 | 28.64 | 8M |
| 01 October 2026 | 23.96 | 28.10 | 22.31 | 27.99 | 22M |
| 30 September 2026 | 70.54 | 71.93 | 29.86 | 30.26 | 23M |
| 29 September 2026 | 72.49 | 73.15 | 68.74 | 70.69 | 2M |
| 28 September 2026 | 68.05 | 74.74 | 67.66 | 73.67 | 1M |
| 25 September 2026 | 71.60 | 71.81 | 67.55 | 68.43 | 967,300 |
| 24 September 2026 | 67.04 | 71.41 | 66.75 | 70.95 | 1M |
| 23 September 2026 | 68.60 | 68.60 | 67.10 | 67.49 | 765,900 |
| 22 September 2026 | 66.59 | 68.76 | 66.00 | 68.64 | 1M |
| 21 September 2026 | 67.18 | 67.41 | 65.74 | 66.43 | 1M |
| 18 September 2026 | 68.08 | 68.72 | 66.57 | 66.88 | 4M |
| 17 September 2026 | 69.51 | 70.81 | 67.41 | 68.39 | 1M |
| 16 September 2026 | 65.67 | 69.87 | 65.34 | 68.45 | 1M |
| 15 September 2026 | 65.31 | 65.93 | 62.86 | 65.72 | 1M |
| 14 September 2026 | 66.79 | 66.90 | 65.13 | 65.31 | 1M |